Keyi Pharma

The national drug alliance procurement office has released a notification indicating that China Meheco Keyi Pharma Co., Ltd’s ganciclovir failed a production site inspection. As a result, the company will lose its tender within the fifth volume-based procurement (VBP) round. The Hubei Medical Products Administration bureau has suspended the manufacturing…